Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-02-28
2006-02-28
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07005420
ABSTRACT:
A copolymer comprising an N-acylated derivative, and a composition comprising said copolymer and a polypeptide, said polypeptide comprising at least one effective ionogenic amine, wherein at least 50 percent, by weight, of said polypeptide present in said composition is ionically bound to said polymer.
REFERENCES:
patent: 4675189 (1987-06-01), Kent et al.
patent: 4767628 (1988-08-01), Hutchinson
patent: 5271945 (1993-12-01), Yoshioka et al.
patent: 5665702 (1997-09-01), Shalaby et al.
patent: 5821221 (1998-10-01), Shalaby et al.
patent: 6479457 (2002-11-01), Shalaby et al.
patent: 6794364 (2004-09-01), Shalaby et al.
patent: 0 482 649 (1992-04-01), None
patent: 0 486 959 (1992-05-01), None
patent: 0 525 813 (1993-02-01), None
patent: 0 544 000 (1993-06-01), None
patent: 0 643 963 (1995-03-01), None
patent: 0 544 000 (1995-06-01), None
patent: 212662 (1994-08-01), None
patent: 63 25879 (1988-10-01), None
patent: 63 258579 (1988-10-01), None
patent: 95/04752 (1995-12-01), None
patent: 96/04927 (1996-02-01), None
patent: 96/39160 (1996-12-01), None
Domard et al., “Preparation and Characterization of Fully Deacetylated Chitosan”, Int. J. Biol. Macromol., 5:49-52, 1983.
Jameela et al., “Cross-linked Chitosan Microspheres as Carriers for Prolonged Delivery of Macromolecular Drugs”, J. Biomater. Sci. Polymer Edn., 6:621-632, 1994.
Mima et al., “Highly Deacetylated Chitosan and Its Properties”, Journal of Applied Polymer Sciences, 28:1909-1917, 1983.
Song et al., “Pharmacokinetic Characteristics and Antitumor Activity of the N-Succinyl-chitosan-Mitomycin . . . ”, Biol. Pharm. Bull, 16:48-54, 1993.
Song et al., “Synthesis and Drug-Release Characteristics of the Conjugates of Mitomycin C with N-Succinyl chitosan and Carboxymethyl-chitin”, Chem. Pharm. Bull, 40:2822-2825, 1992.
Song et al., “Drug Release and Antitumor Characteristics of N-Succinyl-chitosan-mitomycin C as an Implant”, 1996. J. Controlled Release 42:93-100.
Tokura et al., “Induction of Drug Specific Antibody and the Controlled Release of Drug by 6-0-Carboxmethyl Chitin”, Journal of Controlled Release, 28:235-241, 1994.
Watanabe et al., “6-0-Carboxymethyl-Chitin (CM-chitin) as a Drug Carrier”, Chem. Pharm. Bull, 38:506-509, 1990.
Domard, et al., “Preparation and Characterization of Fully Deacetylated Chitosan,” 1983, Int. J. Biol. Macromol., 5:49-52.
Jameela, et al., “Cross-linked Chitosan Microspheres as Carriers for Prolonged Delivery of Macromolecular Drugs,” 1994, J. Biomater. Sci. Polymer Edn., 6:621-632.
Mima, et al., “Highly Deacetylated Chitosan and Its Properties,” 1983, J. Applied Polymer Sci., 28:1909-1917.
Song, et al., “Synthesis and Drug-Release Characteristics of the Conjugates of Mitomycin C with N-Succinyl Chitosan and Carboxmethyl-chitin” 1992, Chem. Pharm. Bull., 40:2822-2825.
Song, et al., “Pharmacokinetic Characteristics and Antitumor Activity of the N-Succinyl-chitosan-Mitomycin Conjugate and the Carboxymethyl-chitin-Mitomycin C Conjugate,” 1993, Biol. Pharm. Bull., 16:48-54.
Song, et al., “Drug Release and Antitumor Characteristics of N-Succinyl-chitosan-mitomycin C as an Implant,” 1996, J. Controlled Release 42:93-100.
Tokura, et al., “Induction of Drug Specific Antibody and the Controlled Release of Drug by 6-0-Carboxymethyl Chitin,” 1994, J. Controlled Release 28:235-241.
Watanabe, et al., “6.0-Carboxymethyl-Chitin (CM-chitin) as a Drug Carrier,” 1990, Chem. Pharm. Bull., 38:506-509.
Ignatious Francis X.
Jackson Steven A.
Moreau Jacques-Pierre
Russell Ruth M.
Shalaby Shalaby W.
Audet Maury
Feeney Alan F.
Fish & Richardson
Ipsen Manufacturing Ireland Limited
Morrill Brian R.
LandOfFree
Ionic molecular conjugates of N-acylated derivatives of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ionic molecular conjugates of N-acylated derivatives of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ionic molecular conjugates of N-acylated derivatives of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3686989